Chemoinformaics analysis of GANOLUCIDIC-ACID-E
Molecular Weight | 484.677 | nRot | 5 |
Heavy Atom Molecular Weight | 440.325 | nRig | 24 |
Exact Molecular Weight | 484.319 | nRing | 4 |
Solubility: LogS | -4.746 | nHRing | 0 |
Solubility: LogP | 4.217 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 83.4489 |
nHD | 2 | BPOL | 46.7451 |
QED | 0.474 |
Synth | 4.912 |
Natural Product Likeliness | 3.416 |
NR-PPAR-gamma | 0.777 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.646 |
Pgp-sub | 0.001 |
HIA | 0.044 |
CACO-2 | -5.266 |
MDCK | 0.0000188 |
BBB | 0.524 |
PPB | 0.909892 |
VDSS | 0.525 |
FU | 0.0522191 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.785 |
CYP2c19-inh | 0.034 |
CYP2c19-sub | 0.895 |
CYP2c9-inh | 0.235 |
CYP2c9-sub | 0.889 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.271 |
CYP3a4-inh | 0.174 |
CYP3a4-sub | 0.33 |
CL | 10.325 |
T12 | 0.275 |
hERG | 0.017 |
Ames | 0.013 |
ROA | 0.074 |
SkinSen | 0.034 |
Carcinogencity | 0.132 |
EI | 0.01 |
Respiratory | 0.94 |
NR-Aromatase | 0.677 |
Antiviral | Yes |
Prediction | 0.723813 |